Assessment of bioequivalence of rifampicin, isoniazid and pyrazinamide in a four drug fixed dose combination with separate formulations at the same dose levels
- 5 December 2001
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 233 (1-2) , 169-177
- https://doi.org/10.1016/s0378-5173(01)00939-5
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC methodJournal of Pharmaceutical and Biomedical Analysis, 1999
- The promise and reality of fixed-dose combinations with rifampicinTubercle and Lung Disease, 1994